OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	78
Improving Medication Adherence in Asthma	59
Pneumonia After Solid Organ Transplantation	59
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	50
Sleep, Circadian Rhythms, and Lung Cancer	49
Mechanical Ventilation for COVID-19 Patients	40
	37
Diffuse Alveolar Hemorrhage	36
Severe Infections Due to Respiratory Viruses	27
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	27
Nonmalignant Pleural Effusions	27
	25
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	20
Prevention of Aspiration: Oral Care, Antibiotics, Others	19
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function	18
Lung Transplant for Chronic Obstructive Pulmonary Disease	18
Impact of Marijuana Use on Lung Health	17
Indwelling Pleural Catheter: Management of Complications	17
Imaging in the Intensive Care Unit	17
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	17
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	17
	17
COVID-19-Related Pleural Diseases	16
Management of Dyspnea in Patients with Neuromuscular Disorders	16
Antibiotic Strategies for Severe Community-Acquired Pneumonia	15

The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	15
Deployment-Related Respiratory Disease: Where Are We?	15
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	14
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	13
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	12
Pulmonary Physiology and Medicine of Diving	12
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	12
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	12
Understanding the Updates in the Asthma Guidelines	11
Definition and Epidemiology of Sepsis	11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	11
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	11
How to Survive Sepsis: Patient Testimonial	10
Lung Cancer in Special Populations	10
	10
Bronchoscopic Lung Volume Reduction: A Review	10
Lung Cancer Progress and Promise: Shaping the Future of Care	10
Work-Related Sleep Disorders: Causes and Impacts	10
Updates in Lung Cancer Screening: A Decade of Evidence	10
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	10
Survivorship Challenges and Supportive Care in Lung Cancer	10
Management of Acutely Decompensated Pulmonary Hypertension	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	9
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	9
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Corticosteroid Treatment in Septic Shock	9
Immunopathogenesis of Sarcoidosis	9
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	8
Malignant Central Airway Obstruction: What's New?	8
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Aspergillus and the Lung	8
Intra-abdominal Infections	8
Pertussis Vaccination: The Challenges Ahead	8
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	8
Arterial Blood Gases and Acid–Base Regulation	7
“Long Haulers”	7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	7
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Sleep and Circadian-Related Outcomes after Critical Illness	7
Glucocorticoid Treatment in Community-Acquired Pneumonia	7
Aspiration Pneumonia: Preface	7
	7
Severe Community-Acquired Pneumonia	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	7

Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	6
Pulmonary Hypertension Associated with Left Heart Disease	6
Use of Antiviral Agents and other Therapies for COVID-19	6
HIV and COVID-19 Disease	6
Control of Breathing	6